BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Pasithea Therapeutics Announces Pricing of $5 Million Public Offering

  May 7, 2025

   · 

  4 min read
• Press Releases

  Bulletin from the Annual General Meeting of Vicore Pharma Holding AB (publ)

  May 7, 2025

   · 

  4 min read
• Press Releases

  FDA Approves New, Low-Dose Chlorthalidone for the Treatment of Hypertension in Adults: HemiClor™ (12.5 mg chlorthalidone)

  May 7, 2025

   · 

  4 min read
• Press Releases

  LIB Therapeutics Announces Key Results from Presentations at 2025 European Atherosclerosis Society Meeting in Glasgow May 5-6

  May 7, 2025

   · 

  5 min read
• Press Releases

  Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates

  May 7, 2025

   · 

  9 min read
• Press Releases

  BioAtla Reports First Quarter 2025 Financial Results and Highlights Recent Progress

  May 7, 2025

   · 

  14 min read
• Press Releases

  Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance

  May 7, 2025

   · 

  28 min read
• Press Releases

  Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - May 6, 2025

  May 7, 2025

   · 

  1 min read
• Press Releases

  CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

  May 7, 2025

   · 

  19 min read
• Press Releases

  Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

  May 7, 2025

   · 

  1 min read